典型文献
Chinese expert consensus on oral drugs for the treatment of mature B-cell lymphomas(2020 edition)
文献摘要：
Oral drugs such as ibrutinib play an important role in the treatment of mature B-cell lymphoma(BCL)due to their reliable efficacy,manageable safety,high accessibility,and convenience for use.Still,no guidelines or consensus focusing on oral drug therapies for BCL is available.To provide a reference of oral agent-based treatment for mature BCL,a panel of experts from the Lymphocyte Disease Group,Chinese Society of Hematology,Chinese Medical Association conducted an extensive discussion and reached a consensus on oral drugs for Chinese BCL patients on the basis of the current application status of oral drugs in China,combined with the latest authoritative guidelines in the world and current research reports.This consensus reviewed the application of oral drugs in the treatment of BCL and the latest research and provided appropriate recommendations on the use of oral drugs for indolent or aggressive BCL patients.With the deepening of research and the development of standardized clinical applications,oral medications will bring better treatment to BCL patients,enabling more patients to benefit from them.
文献关键词：
中图分类号：
作者姓名：
Suning Chen;Weili Zhao;Jianyong Li;Depei Wu;on behalf of Lymphoid Disease Group;Chinese Society of Hematology;Chinese Medical Association
作者机构：
National Clinical Research Center for Hematologic Diseases,Suzhou 215006,China;Jiangsu Institute of Hematology,the First Affiliated Hospital of Soochow University,Suzhou 215006,China;Shanghai Institute of Hematology,State Key Laboratory of Medical Genomics,National Research Center for Translational Medicine at Shanghai,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Department of Hematology,The First Affiliated Hospital of Nanjing Medical University,Jiangsu Province Hospital,Collaborative Innovation Center for Cancer Personalized Medicine,Nanjing 210029,China
文献出处：
引用格式：
[1]Suning Chen;Weili Zhao;Jianyong Li;Depei Wu;on behalf of Lymphoid Disease Group;Chinese Society of Hematology;Chinese Medical Association-.Chinese expert consensus on oral drugs for the treatment of mature B-cell lymphomas(2020 edition))[J].医学前沿,2022(05):815-826
A类：
B类：
Chinese,consensus,oral,drugs,treatment,mature,cell,lymphomas,edition,Oral,such,ibrutinib,play,important,role,BCL,due,their,reliable,efficacy,manageable,safety,high,accessibility,convenience,use,Still,no,guidelines,focusing,therapies,available,To,reference,agent,panel,experts,from,Lymphocyte,Disease,Group,Society,Hematology,Medical,Association,conducted,extensive,discussion,reached,patients,basis,current,status,China,combined,latest,authoritative,world,research,reports,This,reviewed,provided,appropriate,recommendations,indolent,aggressive,With,deepening,development,standardized,clinical,applications,medications,will,bring,better,enabling,more,benefit,them
AB值：
0.539029
相似文献
机标中图分类号，由域田数据科技根据网络公开资料自动分析生成，仅供学习研究参考。
